DOI QR코드

DOI QR Code

Properties of hydrolyzed α-lactalbumin, β-lactoglobulin and bovine serum albumin by the alcalase and its immune-modulation activity in Raw 264.7 cell

  • Yu, Jae Min (Department of Animal Bio-system Science, College of Agriculture and Life Sciences, Chungnam National University) ;
  • Son, Ji Yoon (Department of Animal Bio-system Science, College of Agriculture and Life Sciences, Chungnam National University) ;
  • Renchinkhand, Gerelyuya (Department of Animal Bio-system Science, College of Agriculture and Life Sciences, Chungnam National University) ;
  • Kim, Kwang-Yeon (Department of Animal Bio-system Science, College of Agriculture and Life Sciences, Chungnam National University) ;
  • Sim, Jae Young (Dairy and Food Science Department, South Dakota State University) ;
  • Nam, Myoung Soo (Department of Animal Bio-system Science, College of Agriculture and Life Sciences, Chungnam National University)
  • Received : 2020.04.17
  • Accepted : 2020.07.10
  • Published : 2020.09.01

Abstract

This study investigated the effects of the proteolytic hydrolysates of α-lactalbumin (LA), β-lactoglobulin (LG) and bovine serum albumin (BSA) by alcalase on inflammatory cytokines. The proteolytic hydrolysates were separated into two fraction of peptides, ≤ 10,000 Da and > 10,000 Da, respectively, because various low molecular weight peptides were generated during the hydrolysis reaction time. Among the hydrolysate peptides, BSA (all types), β-LG (> 10,000 Da), and α-LA (> 10,000 Da) showed an inhibitory activity against thymic stromal lymphopoietin (TSLP) mRNA expression in lipopolysaccharide-induced RAW264.7 murine macrophages. α-LA (> 10,000 Da), β-LG (hydrolysates), and BSA (> 10,000 Da) showed an inhibitory activity against tumor necrosis factor (TNF)-α expression. α-LA (all types), β-LG (hydrolysates, > 10,000 Da), and BSA (> 10,000 Da) showed an inhibitory activity against interleukin-6 (IL-6) expression. α-LA (> 10,000 Da), β-LG (> 10,000 Da), and BSA (all types) showed an inhibitory activity against inducible nitric oxide synthase (iNOS) expression. α-LA (> 10,000 Da), β-LG (> 10,000 Da), and BSA (all types) showed an inhibitory activity against cyclooxygenase (COX)-2 expression. The lowest level of TNF-α production was measured with α-LA (> 10,000 Da) and β-LG (> 10,000 Da) for all types, and a similar low level was measured for all types of BSA. The highest level of IL- 6 production was measured with α-LA (≤ 10,000 Da) among α-LA, β-LG, and IL-6. The low level of NO production was similar with α-LA, β-LG, and BSA but not with α-LA (≤ 10,000 Da). These potential peptides from whey protein hydrolysates could be used for food, medicinal, and industrial applications.

Keywords

References

  1. Bounous G, Gold P. 1991. The biological activity of undenatured dietary whey proteins: Role of glutathione. Clinical and Investigative Medicine 14:296-309.
  2. Carvalho-Silva LB, Pacheco MTB, Bertoldo R, Carvalho-Veloso C, Teodore LC, Giusti-Paiva A, Lollo PCB, Soncini R. 2012. Anti-inflammatory activities of enzymatic (alcalase) hydrolysate of a whey protein concentrate. African Journal of Biotechnology 11:2993-2999.
  3. FitzGerald RJ, Meisel H. 2000. Milk protein hydrolysates and bioactive peptides. In: Advances in Dairy Chemistry. Fox PF and McSweeney PLH 3rd ed. pp. 675-698. Kluwer Academic/Plenum Publishers, NY, USA.
  4. Gill HS, Coull FR, Rutherfurd KJ, Cross ML. 2000. Immunoregulatory peptides in bovine milk. The British Journal of Nutrition 84:S111-S117.
  5. Gobbetti M, Minervini F, Rizzello CG. 2004. Angiotensin I-converting enzyme inhibitory and antimicrobial bioactive peptides. International Journal of Dairy Technology 57:173-188. https://doi.org/10.1111/j.1471-0307.2004.00139.x
  6. Gobbetti M, Minervini F, Rizzello CG. 2007. Bioactive peptides in dairy products. In: Handbook of food products manufacturing. Vol. 2, Edited by Hui YH. pp. 489-517. John Wiley & Sons Inc., Hoboken, NJ, USA.
  7. Huth PJ, DiRienzo DB, Miller GD. 2004. Major scientific advances with dairy foods in nutrition and health. Journal of Dairy Science 89:1207-1221. https://doi.org/10.3168/jds.S0022-0302(06)72190-7
  8. Kang K, Stevens SR. 2003. Pathophysiology of atopic dermatitis. Clinical Dermatology 21:116-121. https://doi.org/10.1016/S0738-081X(02)00361-9
  9. Kitts DD, Weiler K. 2003. Bioacive proteins and peptides from food sources. Applications of bioprocesses used in isolation and recovery. Current Pharmaceutical Design 9:1309-1323. https://doi.org/10.2174/1381612033454883
  10. Ma Y, Liu J, Shi H, Yu L. 2016. Isolation and characterization of anti-inflammatory peptides derived from whey protein. Journal of Dairy Science 99:6902-6912. https://doi.org/10.3168/jds.2016-11186
  11. Marshall K. 2004. Therapeutic applications of whey protein. Alternative Medicine Review 9:136-156.
  12. Meisel H, FitzGerald RJ. 2000. Opioid peptides encrypted in intact milk protein sequences. British Journal of Nutrition 84:27-31. https://doi.org/10.1017/S000711450000221X
  13. Meisel H, Schlimmme E. 1994. Inhibitors of angiotensin-converting enzyme derived from bovine casein (casokinsins). In: Brantl V, Teschemacher H, ${\kappa}$-casomorphins and related peptides: Recent developments. pp. 27-33. VCH, Weinheim, Germany.
  14. Nagoaka S, Futamura Y, Miwa K, Takako A, Yamauchi K, Kanamaru Y, Tadashi K, Kuwata T. 2001. Identification of novel hypocholesterolemic peptides derived from bovine milk ${\beta}$-lactoglobulin. Biochemical and Biophysical Research Communication 281:11-17. https://doi.org/10.1006/bbrc.2001.4298
  15. Oranje AP, de Waard-van der Spek FB. 2002. Atopic dermatitis: Review 2000 to January 2001. Current Opin Pediatr 14:410-413. https://doi.org/10.1097/00008480-200208000-00009
  16. Petrillo EW Jr, Ondetti MA. 1982. Angiotensin converting enzyme inhibitors: Medicinal chemistry and biological actions. Medicinal Research Reviews 2:1-14. https://doi.org/10.1002/med.2610020103
  17. Renchinkhand G, Bae HC, Jeong SG, Nam MS. 2012. Isolation of whey protein and hydrolysis pattern of whey protein by proteolytic enzyme. Korean Journal of Agricultural Science 39:561-568. [in Korean] https://doi.org/10.7744/cnujas.2012.39.4.561
  18. Rival SG, Boeriu CG, Wichers HJ. 2001. Caseins and casein hydrolysates. 2. Antioxidativeproperties and relevance to lipoxygenase inhibition. Journal of Agricultural and Food Chemistry 49:295-302. https://doi.org/10.1021/jf0003911
  19. Seibert K, Masferrer JL. 1994. Role of inducible cyclooxygenase (COX-2) in inflammation. Receptor Spring 4:17-23.
  20. Sharma JN, AI-Omran A, Parvathy S. 2007. Role of nitric oxide in inflammatory diseases. Inflammopharmacology 15:252-259. https://doi.org/10.1007/s10787-007-0013-x
  21. Smyth M, Fitz-Gerald RJ. 1998. Relationship between some characteristics of WPC hydrolysates and the enzyme complement in commercially available proteinase preparations. International Dairy Journal 8:819-827. https://doi.org/10.1016/S0958-6946(98)00121-6
  22. Son JY, Bae HC, Renchinkhand G, Nam MS, Kim WS. 2020. Effects of lactoferrin hydrolysates on inflammatory cytokine modulation in HEK-293, RBL-2H3, and HMC-1 cells. Korean Journal of Agricultural Science 47:83-93. [in Korean]
  23. Suetsuna R, Ukeda H, Ochi H. 2000. Isolation and characterization of free radical scavenging activities peptides derived from casein. The Journal of Nutritional Biochemistry 11:128-131. https://doi.org/10.1016/S0955-2863(99)00083-2
  24. Tanaka T, Narazaki M, Kishimoto T. 2014. IL-6 in inflammation, immunity, and disease. Cold Spring Harbor Perspectives in Biology. DOI: https://doi.org/10.1101/cshperspect.a016295
  25. Tavares TG, Spindola H, Longato G, Pintado ME, Carvalho JE, Malcata FX. 2013. Antinociceptive and anti-inflammatory effects of novel dietary protein hydrolysate produced from whey by protease of Cynara cardunculus. International Dairy Journal 32:156-162. https://doi.org/10.1016/j.idairyj.2013.05.010
  26. Wakabayashi H, Takase M, Tomita M. 2003. Lactoferrin derived from milk protein lactoferrin. Current Pharmaceutical Design 9:1277-1287. https://doi.org/10.2174/1381612033454829
  27. Walzem RL, Dillard CJ, German JB. 2002. Whey components: Millennia of evolution create functionalities for mammalian nutrition: What we know and what we may be overlooking. Critical Reviews in Food Science and Nutrition 42:353-375. https://doi.org/10.1080/10408690290825574
  28. Yoo J, Omori M, Gyarmati D, Zhou B, Aye T, Brewer A, Comeau MR, Campbell DJ, Ziegler SF. 2005. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. The Journal of Experimental Medicine 202:541-549. https://doi.org/10.1084/jem.20041503
  29. Zelova H, Hosek J. 2013. $TNF-{\alpha}$ signaling and inflammation: interactions between old acquaintances. Inflammation Research 62:641-651. https://doi.org/10.1007/s00011-013-0633-0